Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
WA
WarrenAI
Not InvestedBased on Analyst Price Targets
Decisiveally Navigating Challenges For Enhanced Financial Health And Market Position
US$69.1
FV
4.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days agoauthor updated this narrative
JU
julio
Not InvestedCommunity Contributor
CVS VALUATION
US$63.3
FV
9.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
18 days agoauthor updated this narrative
CVS Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$61.00 |
52 Week High | US$83.25 |
52 Week Low | US$52.77 |
Beta | 0.51 |
11 Month Change | 0.61% |
3 Month Change | -9.20% |
1 Year Change | -18.24% |
33 Year Change | -25.93% |
5 Year Change | 9.50% |
Change since IPO | 9,191.39% |
Recent News & Updates
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21Recent updates
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20Shareholder Returns
CVS | US Healthcare | US Market | |
---|---|---|---|
7D | 2.4% | 0.5% | -2.4% |
1Y | -18.2% | 5.7% | 17.5% |
Return vs Industry: CVS underperformed the US Healthcare industry which returned 5.7% over the past year.
Return vs Market: CVS underperformed the US Market which returned 17.5% over the past year.
Price Volatility
CVS volatility | |
---|---|
CVS Average Weekly Movement | 6.2% |
Healthcare Industry Average Movement | 7.1% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
CVS fundamental statistics | |
---|---|
Market cap | US$73.63b |
Earnings (TTM) | US$7.32b |
Revenue (TTM) | US$359.66b |
10.5x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVS income statement (TTM) | |
---|---|
Revenue | US$359.66b |
Cost of Revenue | US$307.32b |
Gross Profit | US$52.34b |
Other Expenses | US$45.02b |
Earnings | US$7.32b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 07, 2024
Earnings per share (EPS) | 5.83 |
Gross Margin | 14.55% |
Net Profit Margin | 2.04% |
Debt/Equity Ratio | 86.5% |
How did CVS perform over the long term?
See historical performance and comparison